Evaluation of esketamine adverse event from the FAERS database and published case reports

被引：0
|
作者：
Brendle, Madeline [1 ]
Malone, Daniel [1 ]
Zapata, Lorenzo Villa [2 ]
机构：
[1] Univ Utah, Dept Pharmacotherapy, Coll Pharm, Salt Lake City, UT 84112 USA
[2] Mercer Univ, Dept Pharm Practice, Coll Pharm, Macon, GA 31207 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [1] The correlation of Esketamine with specific adverse events: a deep dive into the FAERS database
    Jiang, Ying
    Du, Zhiqiang
    Shen, Yuan
    Zhou, Qin
    Zhu, Haohao
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2023,
  • [2] The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS)
    Mcintyre, Roger S.
    Mansur, Rodrigo B.
    Rosenblat, Joshua D.
    Teopiz, Kayla M.
    Kwan, Angela T. H.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
  • [3] Completeness of Published Case Reports on Suspected Adverse Drug Reactions Evaluation of 100 Reports from a Company Safety Database
    Impicciatore, Piero
    Mucci, Massimiliano
    [J]. DRUG SAFETY, 2010, 33 (09) : 765 - 773
  • [4] Neratinib safety evaluation: real-world adverse event analysis from the FAERS database
    Fan, Yunhe
    Wu, Teng
    Xu, Pengyang
    Yang, Chuanli
    An, Jie
    Zhang, Haijia
    Abbas, Mureed
    Dong, Xiushan
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [5] Completeness of Published Case Reports on Suspected Adverse Drug ReactionsEvaluation of 100 Reports from a Company Safety Database
    Piero Impicciatore
    Massimiliano Mucci
    [J]. Drug Safety, 2010, 33 : 765 - 773
  • [6] The quality of published adverse drug event reports
    Kelly, WN
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) : 1774 - 1778
  • [7] Evaluation of Ticagrelor Bleeding Adverse Event Reports Compared to Clopidogrel in the FDA Adverse Events Reporting System (FAERS)
    Fahmy, Ahmed I.
    Mekkawy, Mohamed A.
    Abou-Ali, Adel
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 186 - 186
  • [8] BEVACIZUMAB-ASSOCIATED ESOPHAGEAL PERFORATIONS: A CASE SERIES FROM THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) DATABASE
    Wichelmann, Thomas Adam
    Weaver, Mandy
    AbdulMujeeb, Sufyan
    Ehnrenpreis, Eli D.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S16 - S16
  • [9] Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS)
    Ángel Oteo-Álvaro
    Carlos Goicoechea García
    Alejandra Inocencio Sánchez
    Carlo Alemany Santamaria
    Javier de Diego-Adeliño
    [J]. Osteoporosis International, 2023, 34 : 1799 - 1804
  • [10] Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS)
    Oteo-Alvaro, Angel
    Goicoechea Garcia, Carlos
    Inocencio Sanchez, Alejandra
    Alemany Santamaria, Carlo
    de Diego-Adelino, Javier
    [J]. OSTEOPOROSIS INTERNATIONAL, 2023, 34 (10) : 1799 - 1804
12345